• Torin2: Potent mTOR Inhibitor for Precision Cancer Research

  2026-06-08

  Torin2 is a highly potent and selective mTOR inhibitor with nanomolar efficacy and broad utility in cancer research. Its superior binding affinity and bioavailability allow effective mTOR pathway inhibition in both in vitro and in vivo settings. Torin2 enables precise dissection of mTOR-dependent cellular processes, including apoptosis, with clear advantages over previous inhibitors.

• PD98059: Selective MEK Inhibitor for MAPK/ERK Pathway Resear

  2026-06-07

  PD98059 is a selective, reversible MEK inhibitor that blocks ERK1/2 phosphorylation, leading to cell cycle arrest and apoptosis in leukemia cell lines. Its use enables precise dissection of MAPK/ERK signaling and is benchmarked for neuroprotection in ischemia models. APExBIO provides validated quality and protocols for research applications.

• Pol II Degradation Triggers Cell Death Independent of Transc

  2026-06-06

  This study reveals that targeted degradation of RNA polymerase II (Pol II) can induce cell death independently of global transcriptional shutdown, challenging longstanding models of transcription-coupled apoptosis. The findings suggest new mechanistic links between Pol II integrity and cellular survival pathways, with implications for cancer research and selective mTOR kinase inhibitor studies.

• Reliable Gene Expression with HotStart Universal 2X Green qP

  2026-06-05

  Explore how the HotStart™ Universal 2X Green qPCR Master Mix (SKU K1170) empowers life science researchers to achieve reproducible, high-specificity real-time PCR gene expression analysis. This scenario-driven guide addresses common laboratory challenges in cell viability and cytotoxicity workflows, providing practical, evidence-based solutions grounded in current literature and validated protocol parameters.

• Lysosomal β-Galactosidase Staining Kit: Precision in Senesce

  2026-06-05

  The Lysosomal β-Galactosidase Staining Kit delivers artifact-free, polystyrene-compatible lysosomal staining, critical for rigorous cellular senescence workflows. Discover how its optimized chemistry streamlines visualization and troubleshooting, bridging latest oncology research with robust lab practice.

• 7ACC2: Monocarboxylate Transporter 1 Inhibitor for Cancer Re

  2026-06-04

  7ACC2 stands out as a dual-action monocarboxylate transporter 1 inhibitor, uniquely targeting both lactate and pyruvate transport to dissect metabolic vulnerabilities in cancer. This article offers actionable protocols, troubleshooting guidance, and translational insights, bridging the latest immunometabolic research with hands-on workflows for advanced cancer metabolism studies.

• Plant Cell Lysis Buffer for WB and IP: Workflow & Troublesho

  2026-06-04

  Unlock robust, non-denaturing protein extraction from plant tissues with APExBIO’s Plant Cell Lysis Buffer for WB and IP. This guide covers experimental workflows, protocol optimization, and troubleshooting strategies for advanced applications such as Western blotting, immunoprecipitation, and co-IP, translating recent mechanistic research into actionable lab practice.

• QX77: Molecular Chaperone Activator for Advanced Autophagy R

  2026-06-03

  QX77 enables researchers to precisely upregulate LAMP2A and Rab11, facilitating robust control of chaperone-mediated autophagy and stem cell differentiation assays. APExBIO’s trusted compound empowers troubleshooting of autophagic flux and lysosomal receptor regulation in diverse experimental models.

• ERK5 and ERK1/2 Pathways in Vitamin D-Induced AML Differenti

  2026-06-03

  This study reveals a distinct and critical role for the ERK5/MAPK pathway in mediating terminal differentiation of acute myeloid leukemia (AML) cells induced by 1α,25-dihydroxy vitamin D3. The findings clarify how selective inhibition of ERK1/2 versus ERK5 differentially modulates differentiation markers and cell cycle arrest, providing mechanistic insight for the development of targeted combination regimens.

• Trametinib (GSK1120212): Precision MEK1/2 Inhibition in Onco

  2026-06-02

  Trametinib (GSK1120212) stands out for its ATP-noncompetitive, high-affinity inhibition of MEK1/2, enabling robust cell cycle G1 arrest and apoptosis modeling in cancer and immunopathology studies. Recent evidence highlights its unique capacity to dissect MEK-ERK signaling in both tumor and autoimmune injury contexts, providing actionable workflows and troubleshooting guidance for advanced researchers.

• Annexin V-APC/7-AAD Apoptosis Kit: Fast, Reliable Apoptosis

  2026-06-02

  The Annexin V-APC/7-AAD Apoptosis Kit enables rapid and precise differentiation of apoptosis and necrosis, streamlining cell death analysis for cancer and translational research. Its one-step protocol and dual-dye system empower researchers to confidently interpret complex biological responses—even in challenging models of epigenetic perturbation.

• Resazurin Sodium Salt: High-Fidelity Cell Viability Indicato

  2026-06-01

  Resazurin sodium salt is the gold-standard fluorogenic oxidation-reduction indicator for sensitive, high-throughput cell viability and cytotoxicity assays. Explore practical protocols, advanced applications in metabolic and liver fibrosis research, and troubleshooting tactics to optimize your results with this APExBIO innovation.

• Potassium Iodide in Immunotherapy Research: Protocols & Adva

  2026-06-01

  Potassium Iodide (KI) is indispensable for thyroid protection and experimental modulation of hormone synthesis, especially in studies requiring precise iodide supplementation. This article details robust KI workflows, highlights troubleshooting strategies, and translates the latest nanotechnology research into actionable lab protocols.

• HotStart 2X Green qPCR Master Mix: Precision for Gene Expres

  2026-05-31

  HotStart™ 2X Green qPCR Master Mix enables high-specificity, reproducible gene expression quantification—ideal for challenging targets and complex samples. Its optimized hot-start Taq inhibition and robust SYBR Green detection streamline workflows for RNA-seq validation, immune profiling, and translational molecular research.

• Distinct Roles of ERK5 and MEK1/2 in Vitamin D3-Induced AML

  2026-05-30

  This study establishes the critical, non-redundant roles of ERK5 and MEK1/2 pathways in the terminal differentiation of myeloid leukemia cells induced by 1α,25-dihydroxyvitamin D3. The findings highlight that inhibiting ERK1/2 broadly suppresses differentiation, while ERK5 inhibition leads to selective marker modulation and cell cycle arrest, informing the design of future combination therapies.

545 records 15/37 page Previous Next First page 上5页 1112131415 下5页 Last page